Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Clin Ter ; 160(2): 115-9, 2009.
Article in Italian | MEDLINE | ID: mdl-19452099

ABSTRACT

AIMS: Mud-bath treatment has a relevant therapeutic activity in reducing symptoms and disabilities in rheumatic diseases, as studies on inflammation process and clinical symptomatology have shown. Objective of this study is to evaluate the efficacy of mud therapy by natural limans of Cervia on clinical parameters in patients with lumbar spine osteoarthrosis (OA). MATERIALS AND METHODS: 30 patients (20 females and 10 males) suffering from lumbar OA, diagnosed by clinical symptoms and X-Ray findings (osteophytosis, morphological changes of vertrebral somes, tightness of intervertebral spaces, alterated lumbar physiologic lordosis) were studied. All patients were examined first when recruited (T0) and after two weeks of therapy (T1). Interviews were submitted in order to estimate functional restrictions and pain. Statistical analysis was performed via t test for paired data. RESULTS: On the basis of the statistical analysis a very significant difference was demonstrated between the average values of the tests before and after the treatment. These results confirm the improvement of the symptoms concerning the pain, the articular functionality and the quality of life. CONCLUSIONS: The results of the study demonstrate the efficacy of the mud-bath treatment with natural limans of Cervia on the patients affected by lumbar spine osteoarthrosis (OA).


Subject(s)
Lumbar Vertebrae , Mud Therapy , Osteoarthritis, Spine/therapy , Adult , Aged , Balneology , Female , Geologic Sediments/chemistry , Humans , Italy , Male , Middle Aged , Mineral Waters/analysis , Quality of Life , Recovery of Function , Temperature
2.
Clin Ter ; 158(6): 533-41, 2007.
Article in Italian | MEDLINE | ID: mdl-18265720

ABSTRACT

Throughout the ages the interest in the use of sea water in medicine has fluctuated from century to century and from nation to nation. In this paper, the historical development of sea medicine from the ancient Egyptians until the 20th century is given. The medical world has viewed it with different opinions, from very enthusiastic to extremely critical, and from beneficial to harmful. In the last decades, thalassotherapy is receiving renewed attention from many medical specialties and health tourists. The aim of this review is that of offer an update on the real therapeutic possibility of the thalassotherapy. However, the exact therapeutic potential of thalassotherapy still remains largely unknown. Better and more profound scientific evidence for its efficacy is therefore warranted, in particular for its effects on the musculoskeletal system and skin. The main researches belong to the activity of thalassotherapy and the clinic outcomes, namely in osteoarthritis patients, were referred.


Subject(s)
Balneology/history , Climatotherapy/history , Heliotherapy/history , Chronic Disease , Eukaryota , Health Facilities/standards , History, 16th Century , History, 17th Century , History, 18th Century , History, 19th Century , History, 20th Century , History, Ancient , History, Medieval , Humans , Italy , Rheumatic Diseases/history , Rheumatic Diseases/therapy
3.
Ann Ig ; 18(2): 179-88, 2006.
Article in Italian | MEDLINE | ID: mdl-16649515

ABSTRACT

In the last decades, quality has imposed itself as a competitive need for firms, and also as a new normative parameter to guarantee the production process and the final product which the costumer buys. In the case of health services, the importance of quality is even greater because of the special value of this service, and the special relationship between the supplier and the costumer/patient. This relationship is often mediated by the State which has to provide the health services and the financial support for them. Thus, also in the case of Thermal Medicine, quality and its certification play a key role for the evaluation of the efficiency of the health service, and tend always more to be part of the health service accreditation process. In this article, we review the development of the idea of quality of service from the ancient Egyptian until the 20th century and we briefly recall the main European and Italian norms. We also examine the norms for the accreditation of the thermal health structures, and we review the main indicators of quality in Thermal Medicine, and the role of scientific research. Finally, we indicate that the cost of the lack of quality can be so prohibitive that the firms which do not follow the new standards, are put out of the market.


Subject(s)
Balneology/standards , Health Resorts/standards , Balneology/legislation & jurisprudence , Europe , Health Resorts/legislation & jurisprudence , Humans , Italy , Mud Therapy/standards , Quality of Health Care , Research , Surveys and Questionnaires
4.
Clin Ter ; 156(1-2): 23-31, 2005.
Article in Italian | MEDLINE | ID: mdl-16080657

ABSTRACT

The authors remind the main epidemiological and clinical findings of Chronic Obstructive Pulmonary Disease (COPD); the prevalence and incidence of COPD is increasing and COPD is now the IV cause of death in the world. Moreover, it is cause of increasing pharmaceutic and hospital charges. COPD has multifactorial etiology, linked to genetic and exogenous factors, as tobacco smoke, air pollution, microbial infections and cold. The GOLD guide lines of the medical therapy of the COPD are showed. The spa therapy of COPD is based on the inhalation use of mineral water, mainly sulphurous and salsojodic. Sulphurous mineral waters have vasodilating activity on vessels of bronchial mucose, improving its trophic state, and increase the production of secretory IgA and muco-ciliary clearance; they have fluidificant activity on bronchial secretion. Clinical trials showed improvement of cough, sputum and functional indexes as FEV1 and CV. Salsojodic mineral waters increase the fluidity of the bronchial mucus, muco-ciliary clearance and the trophism of the bronchial mucose. The authors remind the properties of sulphate and bicarbonate mineral waters in the spa therapy of COPD. Finally authors refer about some effects of spa therapy and climatic-environmental situations on COPD morbidity.


Subject(s)
Balneology/methods , Climate , Mineral Waters/administration & dosage , Pulmonary Disease, Chronic Obstructive/therapy , Aerosols , Air Pollution/adverse effects , Humans , Treatment Outcome
5.
Clin Ter ; 154(3): 181-91, 2003.
Article in Italian | MEDLINE | ID: mdl-12910808

ABSTRACT

The treatment of HCV correlated hepatitis is an important argument, because of the great incidence and prevalence of this disease. At the end of the Eighties, the IFN was the first substance used for HCV correlated hepatitis therapy. The IFN monotherapy with a dose of 3-6 MU for 6-12 months eradicates the infection in the 15% of cases, and cause an histological temporary improvement in a variable number of patients that keep the infection. In the following years, the research on evaluation of the efficacy of the recombinant interferons or interferons made with genetics engineering (IFN alpha 2a, IFN alpha 2b and IFN Consensus) has given results comparable with the results obtained with IFN alpha. Later, it started the experimentations with IFN associated to other substances, for example IFN-ribavirin combination therapy. The treatment IFN-Ribavirin eradicates the infection in 30% of the patients with the genotype 1b and in 60% with the genotype 2 or 3, while this treatment is less efficacious in the patients with the genotype 4. Recently, it started to use the PEG IFN. The pegylation is the combination of a polietylen-glicole molecule with the IFN molecule, so as to prolong its half-life and reduce the dose only one a week, with reduction of the collateral effects. Some studies has shown that the use of PEG-IFN in monotherapy could help the patients with advanced liver complaint. Successive studies are directed to show the efficacy of the PEG-IFN and ribavirin combination therapy. Recent researches put in evidence new substances, that could represent the future for HCV correlated hepatitis therapy. Between these substances we have to highlight the interleukin, the inhibitors of the viral multiplication and the inhibitors of IMPDH (Inosine monophosphate dehydrogenase). At the beginning of 2002 has made the improvement of HCV vaccine known. Actually, in the USA there are in progress human experimentations, and the production of gamma-globuline, that could be effective to prevent the infection.


Subject(s)
Hepatitis C/drug therapy , Adult , Amantadine/administration & dosage , Amantadine/therapeutic use , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Clinical Trials as Topic , Clinical Trials, Phase I as Topic , Clinical Trials, Phase II as Topic , Drug Therapy, Combination , Female , Follow-Up Studies , Genotype , Hepacivirus/genetics , Hepatitis C/complications , Humans , Interferon alpha-2 , Interferon-alpha/administration & dosage , Interferon-alpha/therapeutic use , Interferon-gamma/administration & dosage , Interferon-gamma/therapeutic use , Interferons/administration & dosage , Interferons/therapeutic use , Interleukins/therapeutic use , Male , Meta-Analysis as Topic , Pilot Projects , RNA, Viral/analysis , Recombinant Proteins , Research , Ribavirin/administration & dosage , Ribavirin/therapeutic use , Risk Factors , Time Factors , Viral Hepatitis Vaccines/therapeutic use
6.
Clin Ter ; 154(2): 85-91, 2003.
Article in Italian | MEDLINE | ID: mdl-12856366

ABSTRACT

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the gut wall. GIST have still today controversial aspects of their histogenesis that are reflected on the classification, clinical behaviour and prognosis. The authors analyzed 14 studies observed between 2000 and 2001; also the tumors early classified as leiomyomas, leiomyosarcomas and schwannomas were included in these studies because, on the basis of immunohistochemical analysis, their cells were c-Kit positive. The GIST occurred in 728 patients with the age range of 12 days-96 years with a male predominance (59.3%). The most common symptoms were abdominal pain (25.4%) and gastrointestinal bleeding (23.4%). CT scan was the most important diagnostic technique. Surgery was the only useful treatment; in this study completeness of resection predicted for longer survival. Overall survival was between 21.4% and 88.8%; the percentage of deaths was between 11.1% and 78.5%. Distant metastases, localised in liver and lungs, and locoregional recurrences developed in a percentage between 9% and 68%.


Subject(s)
Gastrointestinal Neoplasms/epidemiology , Sarcoma/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Child , Child, Preschool , Female , Gastrointestinal Neoplasms/classification , Gastrointestinal Neoplasms/diagnosis , Gastrointestinal Neoplasms/pathology , Gastrointestinal Neoplasms/surgery , Humans , Infant , Infant, Newborn , Male , Middle Aged , Proto-Oncogene Proteins c-kit/analysis , Sarcoma/classification , Sarcoma/diagnosis , Sarcoma/pathology , Sarcoma/surgery , Survival Rate
7.
Clin Ter ; 154(1): 45-8, 2003.
Article in Italian | MEDLINE | ID: mdl-12854283

ABSTRACT

The authors remind the historical role of the mud-therapy in the care of chronic degenerative rheumoartrhopaties, namely osteoarthritis. The main researches belong activity of muds on plasmatic hormones, cytokines, endorphins; a great deal of care is devoted to evaluation of efficacy of mud therapy and relating end points. The clinic outcomes of mud therapy, namely in osteoarthritis patients, were referred. Altogether the studies stress the employ of mud therapy in the treatment of osteoarthritis, the consequences of traumas, some dismetabolic chronic arthropaties, and fibromyalgic syndromes.


Subject(s)
Mud Therapy , Rheumatic Diseases/therapy , Arthritis, Rheumatoid/epidemiology , Chronic Disease , Clinical Trials as Topic , Double-Blind Method , Follow-Up Studies , Humans , Italy/epidemiology , Osteoarthritis/epidemiology , Rheumatic Diseases/epidemiology , Time Factors
8.
Clin Ter ; 154(5): 325-35, 2003.
Article in Italian | MEDLINE | ID: mdl-14994922

ABSTRACT

Our purpose was to summarize current knowledge on "multidrug resistance", or MDR, an intrinsic or acquired cross resistance to a variety of structurally and functionally unrelated drugs, still representing one of the major problems in the therapy of cancer and other diseases. MDR depends on various mechanisms, the best known being the activity of ABC transport proteins, mainly Pgp, MDR1 gene product,and MRPs; but also other transporters can cause resistance, for example TAP, a peptide transporter, CFTR, cystic fibrosis transmembrane regulator, ABCG2, or breast cancer resistance protein (BCRP) and LRP, lung resistance protein. MDR has been detected in nearly all types of cancer, because it affects many organs and can occur against a wide number of drugs; it is frequent even in other diseases, such as epilepsy and HIV. We focused on MDR phenomenon in HCC, one of the commonest tumors in the world, and one of the most resistant to pharmacological treatment. This characteristic might be partly determined by a link between MDR and angiogenic phenotypes. The relationship between MDR in hepatocellular carcinoma and the effectiveness of therapeutic treatments has been particularly examined. Finally, the importance to overcome the strong chemoresistance of hepatocellular carcinoma with methods alternative to drugs, namely gene therapy, which makes use of antisense oligonucleotides and anti-MDR1 ribozymes, has been pointed out.


Subject(s)
Carcinoma, Hepatocellular/drug therapy , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Liver Neoplasms/drug therapy , Animals , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/therapy , Cricetinae , Disease-Free Survival , Drug Resistance, Multiple/genetics , Drug Resistance, Neoplasm/genetics , Genetic Therapy , Humans , Liver Neoplasms/genetics , Liver Neoplasms/mortality , Liver Neoplasms/therapy , Mice , Neoplasm Recurrence, Local , Neoplasms, Experimental/drug therapy , Phenotype , Rats , Survival Analysis , Tumor Cells, Cultured/drug effects
9.
Clin Ter ; 153(3): 195-206, 2002.
Article in Italian | MEDLINE | ID: mdl-12161982
10.
Minerva Med ; 92(1): 7-12, 2001 Feb.
Article in Italian | MEDLINE | ID: mdl-11317132

ABSTRACT

BACKGROUND: To evaluate the prevalence and severity of dyspepsia in patients with liver cirrhosis. METHODS: A questionnaire was distributed to 33 consecutive patients suffering from liver cirrhosis (22 males and 11 females, mean age 65.5 years; 24 with post-hepatitis liver cirrhosis and 9 with alcohol- based cirrhosis) to evaluate dyspeptic symptoms. Patients receiving prolonged treatment at home with anti-acid drugs immediately prior to hospitalisation were excluded from the study. RESULTS: Twenty-eight patients complained of dyspeptic disorders. An organic cause of symptoms could not be identified in 8 patients (24.2%), whereas the following were identified as the causes of organic dyspepsia in the remaining 20 patients, in order of frequency: gastroesophageal reflux disease (55%), congestive gastropathy (40%), gastric or duodenal ulcer (30%) and gallbladder stones (35%). Lastly, a combination of at least two of these morbid conditions was found in 10 patients (50%). The severity of dyspeptic symptoms was similar in both organic and functional forms; symptoms tend to occur with moderate intensity, worsening in parallel with the aggravation of liver disease. CONCLUSIONS: Dyspepsia is a very frequent phenomenon in cirrhotic patients; it is normally sustained by an organic cause. The predominance of functional forms in liver cirrhosis is practically the same as that reported in the general population.


Subject(s)
Dyspepsia/epidemiology , Liver Cirrhosis/complications , Aged , Dyspepsia/etiology , Female , Humans , Male , Prevalence , Severity of Illness Index , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...